Computational analysis of epigenetic patterns facilitates diagnosis of unknown hereditary disorders
A new sophisticated computational model, developed by scientists at Lawson Health Research Institute, is bringing an innovative method of diagnosing rare hereditary conditions.
Genome-wide testing of DNA methylation, a mechanism of the epigenome, has been shown to facilitate the diagnosis of previously unsolved cases of neurodevelopmental or congenital abnormalities. The epigenome is any process that can change the expression of a gene without changing the gene sequence.
The latest in a series of research publications around the theme of epigenomic testing applied the new pattern recognition model to DNA samples of 965 patients with neurodevelopmental and congenital anomalies that did not have a definitive diagnosis despite extensive clinical genetic testing. Their DNA, acquired through blood samples, was examined using the new model, and dozens of new cases were resolved.
Current testing of patients who present with neurodevelopmental and congenital anomalies leaves a number of cases undiagnosed or unexplained. “Many families spend years going through repeated testing and assessments, in search of a diagnosis. This process is hard on patients and families, and is a great cost to our health care system,” explains Dr. Bekim Sadikovic, Associate Scientist at Lawson, and Head of the Molecular Genetics Division in the Department of Pathology and Laboratory Medicine, London Health Sciences Centre (LHSC).
While currently there are limited treatment options associated with many of these conditions, providing a specific diagnosis can help physicians better predict the course of the disease, allowing for better planning and support for the patient. This research highlights the value of epigenomic testing in the routine assessment of neurodevelopmental and congenital disorders.
From this research, LHSC will be the first site in the world to offer this type of genetic testing. “We are excited to make this testing accessible to local patients, and across the world. Our lab has partnered and licensed this technology to Greenwood Genetics Laboratories in the United States and Amsterdam University Medical Centre Laboratories in the European Union”, says Dr. Sadikovic. 100 per cent of revenue will be funneled back to support local testing for patients and ongoing research.
Learn more: Research leads to new molecular diagnostic tool
The Latest on: Molecular diagnostic tool
via Google News
The Latest on: Molecular diagnostic tool
- Novel Technologies Driving Infectious Disease...on August 15, 2019 at 2:20 am
Molecular Diagnostics: Polymerase chain reaction (PCR ... Advances in artificial intelligence (AI), computer programming, bioinformatics tools, and cloud technology have enabled the generation of ...
- Europe In-vitro Diagnostics Market Research Report 2019 Study By Manufacturers, Regions, Type And Application Forecast 2024on August 14, 2019 at 5:58 am
Also, key industry players such as Roche diagnostics, Beckman Coulter and others have inculcated advanced technology within the in-vitro diagnostic devices that are largely adopted by the doctors to ...
- Global Molecular Diagnostics Equipment Market Research Report 2019 - Industry Size, Share, Survey and Statisticson August 14, 2019 at 4:42 am
The global Molecular Diagnostics Equipment market is comprehensively and accurately ... It is prepared with the use of industry-best primary and secondary research methodologies and tools. It includes ...
- In-Vitro Diagnostics (IVD) Market Key Reasons for the Present Growth, Demand and Upcoming Business Opportunity with Detailed Foreseen to 2023on August 14, 2019 at 3:39 am
The Data Is Collected From Different Sources Allied To The Global In-Vitro Diagnostics (IVD) And The Research Team Meticulously Analyze The Gathered Data With The Help Of Various Analytical Tools And ...
- LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratoryon August 8, 2019 at 5:58 am
We specialize in molecular, microbiology, and toxicology assays and technology. ASL is also a CDC ARLab Partner that works with the CDC to develop diagnostic tools to better identify emerging ...
- Non-invasive imaging method spots cancer at the molecular levelon August 6, 2019 at 11:51 am
These features, which are not visible in the images acquired with standard operative imaging tools ... spots cancer at the molecular level: Technology could allow doctors to see cancer metastasis in ...
- Global Veterinary Infectious Disease Diagnostics Market to Reach $2.2 Billion by 2024 - Emerging Countries Present Lucrative Opportunitieson August 6, 2019 at 4:30 am
Growing demand for advanced veterinary infectious disease diagnostic tools, increasing demand for ... market is segmented into immunodiagnostics, molecular diagnostics, and other technologies.
- HTG Molecular Diagnostics, Inc. (HTGM) Reports Q2 Loss, Tops Revenue Estimateson August 6, 2019 at 4:15 am
HTG Molecular Diagnostics, Inc. (HTGM) came out with a quarterly loss ... Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an ...
- GENOMIC VISION: Molecular Combing Assay Used to Help Physicians in the Diagnostic of FSHD in More Than 250 Patients Since Its Launch in Chinaon August 5, 2019 at 10:30 pm
GENOMIC VISION is a company specialized in the development of diagnostic solutions for the early detection of cancers and serious genetic diseases and tools for life sciences research. Through the DNA ...
- Global Veterinary Infectious Disease Diagnostics Market Will Grow at a CAGR of 8.4% - Exclusive Report by MarketsandMarketson August 5, 2019 at 6:17 am
Growing demand for advanced veterinary infectious disease diagnostic tools, increasing demand for animal-derived ... Disease Diagnostics Market is segmented into immunodiagnostics, molecular ...
via Bing News